Equity Research Analyst’s Stock Ratings: Campbell Soup Company (CPB), Vericel Corporation (VCEL)

Campbell Soup Company (NYSE:CPB) tinted gains of +0.38% (+0.15 points) to US$39.81. The volume of 2.27 Million shares climbed down over an trading activity of 2.73 Million shares. EPS ratio determined by looking at last 12 month figures is -0.56. Over the same time span, the stock marked US$43.98 as its best level and the lowest price reached was US$32.03. The corporation has a market cap of US$11.73 Billion.

Campbell Soup Company (NYSE:CPB)’s earnings per share has been growing at a -27.1 percent rate over the past 5 year when average revenue increase was noted as 1.5 percent. The return on equity ratio or ROE stands at -12.1 percent while most common profitability ratio return on investment (ROI) was 3 percent. The company’s institutional ownership is monitored at 54.2 percent. The company’s net profit margin has achieved the current level of -1.7 percent and possesses 31.7 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 1 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 2 analysts call it Sell, while 4 think it is Hold. Recently, analysts have updated the overall rating to 3.53. 1 analysts recommended Overweight these shares while 7 recommended Underweight, according to FactSet data.

Vericel Corporation (NASDAQ:VCEL) is worth US$796.28 Million and has recently risen 0.38% to US$18.67. The latest exchange of 0.64 Million shares is below its average trading activity of 630 Million shares. The day began at US$18.6 but the price moved to US$18.37 at one point during the trading and finally capitulating to a session high of US$18.6. The stock tapped a 52-week high of US$21 while the mean 12-month price target for the shares is US$23.75.

Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 7.94, and a price to sales ratio of 8.76. For the past 5 years, the company’s revenue has grown 444.4%, while the company’s earnings per share has grown 50.7%. With an institutional ownership near 84%, it carries an earnings per share ratio of -0.24.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 4 brokerage firms polled by Factset Research. At present, 1 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 0 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 1.4.